Top compounds associated with response to RFXANK


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.033 0.3
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.036 0.3
mRNA Tamoxifen GDSC1000 pan-cancer AAC 0.033 0.3
mRNA SB-431542 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.053 0.3
mRNA SID 26681509 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.05 0.3
mRNA myricetin CTRPv2 pan-cancer AAC -0.038 0.3
mRNA PF-573228 CTRPv2 pan-cancer AAC 0.034 0.3
Download CSV